Trials / Unknown
UnknownNCT03285035
Quality of Life Assessment of Cryotherapy in Esophageal or Gastroesophageal Cancer
Quality of Life Assessment in Patients Receiving Cryotherapy in Addition to Chemotherapy for Palliation of Unresectable Esophageal or Gastroesophageal Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Western Regional Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- —
Summary
Cryoablation combined with chemotherapy on the quality of life of patients with non resectable esophageal or gastroesophageal cancer.
Detailed description
This is a single arm prospective study to determine the effect of cryoablation combined with chemotherapy on the quality of life of patients with non resectable esophageal or gastroesophageal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Administration of questionaires to patients receiving an upper endoscopy with cryotherapy in addition to chemotherapy for esophageal cancer palliation. | Upper endoscopy with cryotherapy using liquid nitrogen. |
Timeline
- Start date
- 2017-07-13
- Primary completion
- 2020-07-13
- Completion
- 2021-01-13
- First posted
- 2017-09-15
- Last updated
- 2019-10-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03285035. Inclusion in this directory is not an endorsement.